Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01930981 · ClinicalTrials.gov registry record
Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life
A clinical trial of Hematologic Malignancies and Other Diagnoses, Comorbidities, and Complications, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 252
- Enrollment target
- 1
- Study location
NCT01930981: Completed study of Hematologic Malignancies and Other Diagnoses, Comorbidities, and Complications, sponsored by Fred Hutchinson Cancer Center.
NCT01930981 is a study of Hematologic Malignancies and Other Diagnoses, Comorbidities, and Complications that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 252 participants, below the 2,706-participant average among 45 other Hematologic Malignancies trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01930981, a study of Hematologic Malignancies and Other Diagnoses, Comorbidities, and Complications, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
We are interested in studying whether and how medical problems other than primary cancer before hematopoietic cell transplantation would impact the profiles of quality of life and toxicities post-transplantation for patients with blood cancers. We want to see if by assessing comorbidities (such as diabetes) early on, we can identify those patients who will have more toxicities or limitations in their quality of life after transplant. The generated information could set the stage for future intervention studies aiming to improve quality of life for patients with blood cancers after transplantation.
Primary Outcome
A 19-item instrument, it assesses physical symptoms and their interference with life.
Conditions Studied
Study Locations (1)
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2012-10 |
| Est. Completion | 2016-06 |
What the finished NCT01930981 record still lists
NCT01930981 is an observational study that tracks outcomes without assigning an intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 2,706-participant average among 45 other Hematologic Malignancies trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Hematologic Malignancies appearing as the primary indexed condition, and to 0 interventions.
NCT01930981 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01930981 about?
NCT01930981 is a clinical study titled "Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life". We are interested in studying whether and how medical problems other than primary cancer before hematopoietic cell transplantation would impact the profiles of quality of life and toxicities post-transplantation for patients with blood cancers. We want to see if by assessing comorbidities (such as d...
What is the current status of trial NCT01930981?
This trial is currently completed. The enrollment target is 252 participants. The study started on 2012-10. Estimated completion is 2016-06.
What conditions does trial NCT01930981 study?
This clinical trial studies the following conditions: Hematologic Malignancies, Other Diagnoses, Comorbidities, and Complications.
Who is sponsoring clinical trial NCT01930981?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01930981 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematologic Malignancies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01930981's enrollment target sits among peer trials
252 9th of 45 higher than 37 of 45 other Hematologic Malignancies trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematologic Malignancies trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RECRUITING · Phase 1
-
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
RECRUITING · Phase 1
-
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
RECRUITING · Phase 1
-
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RECRUITING · Phase 1
-
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation
RECRUITING · Phase 2
-
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia